Did you even read the Company Update? How do you think they're going to uplist at 4 cents? Also, NASDAQ requires a mkt value of at least $45m. Clinical Trials have nothing to do with a reverse split or uplisting.
"The Company is considering an appropriate path to up-list to a major stock exchange in order to enable a broader spectrum of the investment market to participate in Emerald’s stock and also to enhance the recognition and profile of the company."
I suggest you read the whole update before you reply again. Your 2 free cut & pastes have been used.
News 
Market Data 
Discover 
